NCT05859802 - Effects of Physical Therapy and Dalfampridine on Functional Mobility in Non Ambulatory Persons With Multiple Sclerosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 13, 2011

Primary Completion Date

March 3, 2015

Study Completion Date

January 9, 2016

Conditions

Multiple Sclerosis

Interventions

DRUG

Dalfampridine Pill

Subjects were blinded and randomized into 2 groups; Group 1 received physical therapy 2 x a week for 12 weeks while taking dalfampridine 10 mg two times day

DRUG

Placebo

Subjects were blinded and randomized into 2 groups; Group 1 received physical therapy 2 x a week for 12 weeks while taking a placebo pill two times day